Jose E. Manautou
Professor & Department Head/Pharmaceutical Science
Storrs Mansfield
Are you Jose E. Manautou?
How to update your information.
Scholarly Contributions
186 Scholarly Contributions
The modulation of transcriptional expression and inhibition of multidrug resistance associated protein 4 (MRP4) by analgesics and their primary metabolites
2020
Research Type: Journal Article
Acetaminophen-Induced Liver Injury Alters Expression and Activitiesof Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver
2020
Research Type: Journal Article
Multidrug resistance-associated protein 4 (Mrp4) expression and its relationship to obesity and diabetes
2020
Research Type: Poster/Presentation
A lesser-known complication of COVID-19 disease: Liver dysfunction
2020
Research Type: Poster/Presentation
The Role of Bromodomain and Extra-Terminal (BET) Proteins on APAP-Induced Hepatotoxicity
2020
Research Type: Poster/Presentation
Multidrug Resistance-Associated Protein 4 (Mrp4) Is a Novel Genetic Factor in the Pathogenesis of Obesity and Diabetes
2020
Research Type: Poster/Presentation
Conferencia de Cierre: Evidencia emergente de daño hepatico como secuela de COVID-19
2020
Research Type: Poster/Presentation
Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes.
2021
Research Type: Journal Article
The growth of siRNA-based therapeutics: Updated clinical studies
2021
Research Type: Journal Article
lnc-RHL, a novel long non-coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells.
2021
Research Type: Journal Article
Functional characterization of multidrug resistance protein 4 (Abcc4) in the development of hepatic steatosis during compensatory hepatocellular proliferation
2021
Research Type: Poster/Presentation
Liver Regeneration Following Partial Hepatectomy and the Influence of Drug Transporter Function on the Morphology of the Regained Tissue Mass
2021
Research Type: Poster/Presentation
Symposium entitled Recent Advances in Liver Disease: from Non-Alcoholic Fatty Liver Disease (NAFLD) to Fibrosis (José Manautou, Symposium Chair and Speaker). Presentation: “Impact of Multidrug Resistance Protein 4 (Mrp4) Function on Hepatic Lipid. Virtual Congress
2021
Research Type: Poster/Presentation
Non-Alcoholic Fatty Liver Disease and Drug Transporters: What is the Connection?
2021
Research Type: Poster/Presentation